IL27 and rheumatoid arthritis: Sixteen RA patients with disease activity were recruited after an eight-week treatment with leflunomide (LEF), and we found that serum IL-27 level in all 16 patients were significantly decreased by eight-week treatment (p < 0.01, Figure 3A).